Clinical trials
Observational Anosmia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 24 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Unknown status | 10 |
| Recruiting | 9 |
| Active, not recruiting | 4 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Pasteur | 3 |
| AHS Cancer Control Alberta | 2 |
| Ain Shams University | 2 |
| Centre Hospitalier Universitaire de Nīmes | 2 |
| Hospital Sultanah Bahiyah | 2 |
| Massachusetts General Hospital | 2 |
| Michael J. Fox Foundation for Parkinson's Research | 2 |
| National Institute on Drug Abuse (NIDA) | 2 |
| University Hospital, Strasbourg, France | 2 |
| Association "Naso Sano" Onlus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anosmia | 58 |
| COVID-19 | 21 |
| Dysgeusia | 6 |
| Olfaction Disorders | 6 |
| Parkinson Disease | 6 |
| Taste Disorders | 5 |
| Ageusia | 4 |
| Obesity | 4 |
| Alzheimer Disease | 3 |
| Cognitive Dysfunction | 3 |
Trials
Showing 26 to 50 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.